Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 04    source : Ir.biolinerx.com    save search
BioLineRx Announces Positive Top-Line Results from GENESIS Phase 3 Trial of Motixafortide in Stem-Cell Mobilization for Autologous Bone Marrow Transplantation in Multiple Myeloma Patients
Published: 2021-05-04 (Crawled : 11:00) - ir.biolinerx.com
BLRX | $0.6564 2.55% 2.48% 190K twitter stocktwits trandingview |
Health Technology
 | | O: 53.29% H: 29.65% C: -0.2%
bone positive results phase 3 trial topline
Gainers vs Losers
67% 33%

Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.